Bing

SEARCH HISTORY

The first issue involves an ongoing lawsuit between Dr. Zein Obagi, founder of Obagi, and the company. Originally filed in January 2010 in the California courts by Dr. Obagi, the lawsuit made certain claims based on the doctor's 2006 separation-agreement ...
Investopedia · 5/19/2011
Another chapter has been written on the nearly year-long effort by Voce Capital management to get Obagi Medical Products (OMPI) sold. On Monday ... They are my opinions only. Trading stocks is risky — always be sure to know and understand your risk ...
Trefis · 12/6/2012
See what other ETFs contain BMY » See what other stocks are held by PPH » BMY operates in the Drugs & Pharmaceuticals sector, among companies like Ampio Pharmaceuticals Inc. (AMPE) which is down about 5.8% today, and Obagi Medical …
Forbes · 8/8/2011
More from Bing News
Superior Industries International Inc. SUP 1.14 % topped the list of Biggest Percentage Price Decliners among common stocks on the New York Stock Exchange at midday. See the full list. Obagi Medical Products Inc. topped the list of Biggest Percentage …
Wall Street Journal · 1/28/2004
Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is ...
marketwired.com · 4/3/2013
Merz said it sent a letter to Obagi Medical Products Inc.'s (OMPI) board offering to buy all of the company's stock for $22 per share. The news sent Obagi's shares up 14.7 percent to $22.61 in premarket trading Tuesday. Late last month, Valeant ...
Daily Finance · 4/2/2013
OMPI), a dermatology products maker, for about $344 million. Montreal-based Valeant will pay $19.75 per share in cash for Obagi's stock, a 28 percent premium over the Long Beach, California-based company's closing price on Tuesday, Valeant said in a ...
Proactiveinvestors · 3/20/2013
Valeant Pharmaceuticals International, Inc. (VRX) recently announced that the company has entered into a definitive agreement to acquire all of the outstanding common stock of Obagi Medical Products, Inc. (OMPI) for $19.75 per share in cash. The offer ...
Finance Yahoo · 3/21/2013
Wall Street ratings agencies set the tone for today's stock market. Actuant (ATU): Noting seasonal hurdles ... cut Market Perform from Outperform by William Blair. Obagi Medical (OMPI): Shares, no longer trading on fundamentals following an acquisition ...
Minyanville · ByJustin Sharon · 3/21/2013
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation …
News-Medical · 11/20/2010